Examkin

Question

Difficulty: HardGastroenterology and Hepatology

A 4242-year-old man is evaluated in the gastroenterology clinic for a 66-month history of chronic, watery diarrhea and recurrent epigastric pain. His symptoms have persisted despite taking high-dose omeprazole twice daily. Esophagogastroduodenoscopy reveals thickened gastric folds and multiple 11- to 22-cm ulcers in the stomach, duodenal bulb, and descending duodenum. Rapid urease test for Helicobacter pylori is negative. The physician suspects a neuroendocrine tumor. Arrange the following diagnostic and management steps in the most appropriate chronological sequence for this patient's suspected condition.

  1. 1Measure fasting serum gastrin level after appropriately withholding proton pump inhibitor therapy
  2. 2Measure gastric fluid pH
  3. 3Perform a secretin stimulation test
  4. 4Perform somatostatin receptor scintigraphy or Gallium-68 DOTATATE PET/CT

Answer

The correct sequence is: 1) Measure fasting serum gastrin level, 2) Measure gastric fluid pH, 3) Perform a secretin stimulation test, 4) Perform somatostatin receptor scintigraphy or Gallium-68 DOTATATE PET/CT.
The diagnostic algorithm for Zollinger-Ellison syndrome (ZES) follows a strict sequence to avoid false-positive diagnoses and unnecessary procedures. First, a fasting serum gastrin level is measured (after withholding PPIs). Because the most common cause of an elevated gastrin level is achlorhydria (secondary to PPI therapy or autoimmune atrophic gastritis), the second step is measuring gastric pH. A gastric pH <2< 2 confirms that the hypergastrinemia is associated with inappropriate acid hypersecretion. If the gastrin level is markedly elevated (>1000> 1000 pg/mL) alongside low pH, the diagnosis of ZES is established. However, if the gastrin level is non-diagnostically elevated (e.g., 110110-10001000 pg/mL), a secretin stimulation test is the necessary third step; exogenous secretin paradoxically stimulates gastrinoma cells to release gastrin. Only after biochemical confirmation is complete should the final step, tumor localization via somatostatin receptor scintigraphy or Gallium-68 DOTATATE PET/CT, be performed to guide potential surgical resection.

Step-by-Step Solution

1
Identify the suspected diagnosis based on the clinical vignette.
The patient has refractory peptic ulcer disease, distal duodenal ulcers, and chronic diarrhea, which are hallmark features of Zollinger-Ellison syndrome (ZES).
Recognizing the classic presentation of ZES is necessary to determine the appropriate diagnostic algorithm.
2
Determine the initial biochemical screening test.
Measuring a fasting serum gastrin level is the first step.
ZES is caused by a gastrin-secreting tumor. Documenting an elevated gastrin concentration is the mandatory first step, requiring discontinuation of proton pump inhibitors to avoid false-positive results.
3
Determine the step to rule out the most common physiologic cause of hypergastrinemia.
Measuring gastric fluid pH is the second step.
Achlorhydria causes physiologic hypergastrinemia due to loss of negative feedback. A gastric pH <2< 2 confirms that the hypergastrinemia is inappropriate and associated with pathologic acid hypersecretion.
4
Identify the confirmatory test for non-diagnostic gastrin elevations.
The secretin stimulation test is the third step.
If gastrin is elevated but <1000< 1000 pg/mL, exogenous secretin is administered. A paradoxical dramatic rise in gastrin confirms the diagnosis of a gastrinoma.
5
Determine the final step once the diagnosis is confirmed.
Imaging, such as somatostatin receptor scintigraphy or PET/CT, is the final step.
Tumor localization should only be pursued after biochemical confirmation of the disease to avoid finding incidentalomas and to definitively guide surgical management.

Key Concept

The diagnostic algorithm for Zollinger-Ellison syndrome requires sequential biochemical confirmation starting with a fasting serum gastrin level, followed by gastric pH assessment, a confirmatory secretin stimulation test (if gastrin is non-diagnostic), and finally tumor localization using functional imaging.
Rate this question

Topics

Gastroenterology and Hepatology

More questions from this topic